SumaP.SattiMD

Oncology • New Orleans, LA

Staff Physician

Join to view full profile

Dr. Satti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Satti's full profile

Already have an account?

Office
1514 Jefferson Hwy
New Orleans, LA 70121
Phone+1 504-842-4000

Education & Training

Ochsner Clinic FoundationFellowship, Hematology and Medical Oncology, 2006 - 2008
Ochsner Clinic FoundationResidency, Internal Medicine, 2003 - 2006
Kasturba Medical College ManipalClass of 2000

Certifications & Licensure

FL State Medical License 2010 - 2025
LA State Medical License 2006 - 2025
MS State Medical License 2020 - 2025
AL State Medical License 2020 - 2021
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2010 Jan 01
Terminated
Phase 2
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

10 citations
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
Veena Shankaran, Joseph M Unger, Amy K Darke, Jennifer Marie Suga, James L Wade
Journal of the National Cancer Institute. 2022-03-08
8 citations
Outcomes of Patients With Late-Relapse Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Single Institution Experience.
John Kucharczyk, Kamal Kishore Mandalapu, Suma Satti, Marc R. Matrana
Ochsner Journal. 2017-01-01
Primary Undifferentiated Pleomorphic Sarcoma of the Penis.
Hyung Sun Yoo, Suma Satti, Marc R. Matrana
Ochsner Journal. 2017-01-01

Press Mentions

Ochsner Oncologist Named the Leukemia & Lymphoma Society’s MSLA Market 2022 Woman of the YearJune 23rd, 2022